Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (Cytoxan) (AC) response and resistance
- 2 December 2005
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 95 (3) , 229-233
- https://doi.org/10.1007/s10549-005-9009-7
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Gene Expression Profiles Predict Complete Pathologic Response to Neoadjuvant Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy in Breast CancerJournal of Clinical Oncology, 2004
- Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancerThe Lancet, 2003
- A Paradigm for Class Prediction Using Gene Expression ProfilesJournal of Computational Biology, 2002
- Analyzing high-density oligonucleotide gene expression array dataJournal of Cellular Biochemistry, 2000
- Biologic Markers as Predictors of Clinical Outcome From Systemic Therapy for Primary Operable Breast CancerJournal of Clinical Oncology, 1999
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.Journal of Clinical Oncology, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998